Detalhe da pesquisa
1.
APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline.
Nature;
581(7806): 71-76, 2020 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32376954
2.
Association Between Self- and Proxy-Reported Depression and Quality of Life in Mild-Moderate Alzheimer's Disease.
Am J Geriatr Psychiatry;
32(1): 58-67, 2024 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37827916
3.
Comparison of relative change with effect size metrics in Alzheimer's disease clinical trials.
J Neurol Neurosurg Psychiatry;
95(1): 2-7, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37979967
4.
The small HDL particle hypothesis of Alzheimer's disease.
Alzheimers Dement;
19(2): 391-404, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35416404
5.
Brain energy failure in dementia syndromes: Opportunities and challenges for glucagon-like peptide-1 receptor agonists.
Alzheimers Dement;
18(3): 478-497, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34647685
6.
Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria.
Alzheimers Dement;
18(4): 810-823, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34590409
7.
Committee on High-quality Alzheimer's Disease Studies (CHADS) consensus report.
Alzheimers Dement;
18(6): 1109-1118, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34590417
8.
What the Gantenerumab Trials Teach Us about Alzheimer's Treatment.
N Engl J Med;
389(20): 1918-1920, 2023 Nov 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37966291
9.
Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification.
Alzheimers Dement;
17(8): 1365-1382, 2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33559354
10.
A novel sensitive assay for detection of a biomarker of pericyte injury in cerebrospinal fluid.
Alzheimers Dement;
16(6): 821-830, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32301266
11.
A randomized clinical trial to evaluate home-based assessment of people over 75 years old.
Alzheimers Dement;
15(5): 615-624, 2019 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30872114
12.
Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial.
Alzheimers Dement;
15(11): 1427-1436, 2019 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31587995
13.
Vascular dysfunction-The disregarded partner of Alzheimer's disease.
Alzheimers Dement;
15(1): 158-167, 2019 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30642436
14.
Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.
Alzheimers Dement;
15(2): 292-312, 2019 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30555031
15.
Precision pharmacology for Alzheimer's disease.
Pharmacol Res;
130: 331-365, 2018 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29458203
16.
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial.
Lancet;
388(10062): 2873-2884, 2016 12 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27863809
17.
Challenging Assumptions About African American Participation in Alzheimer Disease Trials.
Am J Geriatr Psychiatry;
25(10): 1150-1159, 2017 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28554539
18.
The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model.
Alzheimers Dement;
13(1): 8-19, 2017 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27583651
19.
Diversity in Alzheimer's disease drug trials: Reflections on reporting and social construction of race.
Alzheimers Dement;
18(4): 867-868, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35142024
20.
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.
Lancet;
396(10248): 413-446, 2020 08 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32738937